Jump Financial LLC Takes Position in Azenta, Inc. (NASDAQ:AZTA)

Jump Financial LLC purchased a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 23,703 shares of the company's stock, valued at approximately $1,185,000. Jump Financial LLC owned approximately 0.05% of Azenta at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AZTA. Ballentine Partners LLC grew its holdings in Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after buying an additional 404 shares in the last quarter. Picton Mahoney Asset Management grew its holdings in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock valued at $225,000 after purchasing an additional 576 shares during the period. KBC Group NV increased its position in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund raised its stake in Azenta by 7.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after purchasing an additional 702 shares during the period. Institutional investors and hedge funds own 99.08% of the company's stock.

Analyst Upgrades and Downgrades

AZTA has been the subject of a number of recent analyst reports. Stephens restated an "overweight" rating and set a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd. Needham & Company LLC raised their target price on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th. Finally, Evercore ISI raised their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th.

Azenta Stock Down 1.5 %

NASDAQ AZTA traded down $0.40 on Friday, reaching $26.73. The stock had a trading volume of 603,236 shares, compared to its average volume of 646,541. The stock has a fifty day moving average price of $35.03 and a two-hundred day moving average price of $43.26. Azenta, Inc. has a 12-month low of $24.06 and a 12-month high of $63.58. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -8.97 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.